These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37145856)

  • 1. Implication to Prevent Tachyarrhythmia by Amiodarone Therapy During Durable Left Ventricular Assist Device Supports.
    Kataoka N; Imamura T
    ASAIO J; 2023 Sep; 69(9):e420. PubMed ID: 37145856
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
    Packer DL; Prutkin JM; Hellkamp AS; Mitchell LB; Bernstein RC; Wood F; Boehmer JP; Carlson MD; Frantz RP; McNulty SE; Rogers JG; Anderson J; Johnson GW; Walsh MN; Poole JE; Mark DB; Lee KL; Bardy GH
    Circulation; 2009 Dec; 120(22):2170-6. PubMed ID: 19917887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone decreases plasma brain natriuretic peptide level in patients with heart failure and ventricular tachyarrhythmia.
    Shiga T; Hosaka F; Wakaumi M; Matsuda N; Tanizaki K; Kajimoto K; Shoda M; Hagiwara N; Kasanuki H
    Cardiovasc Drugs Ther; 2003 Jul; 17(4):325-33. PubMed ID: 14618094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic sustained ventricular fibrillation in a patient with left ventricular assist device.
    Busch MC; Haap M; Kristen A; Haas CS
    Ann Emerg Med; 2011 Jan; 57(1):25-8. PubMed ID: 20674087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study between landiolol and amiodarone for therapeutic efficacy after open heart surgery].
    Ito S; Konishi T; Imazuru T; Matsuzaki K; Jikuya T
    Kyobu Geka; 2011 Dec; 64(13):1141-4. PubMed ID: 22242289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic ventricular fibrillation in continuous flow left-ventricular assist device.
    Smith ME; Moak JH
    Am J Emerg Med; 2021 Nov; 49():130-132. PubMed ID: 34102458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of tachycardia-induced cardiomyopathy with LVAD in a 12-year-old boy.
    Tatewaki H; Masuda M; Nishida T; Kaji Y; Ushinohama H; Morita S; Yasui H
    Ann Thorac Surg; 2005 Aug; 80(2):e5-7. PubMed ID: 16039171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awake and aware with ongoing ventricular fibrillation during LVAD treatment: is it possible?
    Mott IH; Poulsen SH; Løgstrup BB
    BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32327464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Ventricular Assist Device Thrombosis-Amiodarone-Induced Hyperthyroidism: Causal Link?
    Rajapreyar I; Acharya D; Tallaj J; Hornbuckle L; Sharpton J; Joly J; Pamboukian S
    ASAIO J; 2019 Feb; 65(2):e18-e20. PubMed ID: 29517512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of amiodarone.
    Coceani M
    JAMA; 2007 Dec; 298(22):2617-8; author reply 2618. PubMed ID: 18073355
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients.
    Myers M; Peter T; Weiss D; Nalos PC; Gang ES; Oseran DS; Mandel WJ
    Am Heart J; 1990 Jan; 119(1):8-14. PubMed ID: 2296879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value and limitations of electropharmacological tests in the selection of anti-arrhythmic therapy in malignant ventricular tachyarrhythmia].
    Klein H
    Cardiologia; 1985 Jul; 30(7):487-92. PubMed ID: 3834995
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between amiodarone and ventricular tachycardia after left ventricular assist device implant: a single-center experience.
    Larson J; Gondi K; Chou A; Deshmukh A; Cascino TM; Ghannam M; Judge EC; Latchamsetty R; Jongnarangsin K; Aaronson KD; Pagani FD; Bogun F; Liang JJ
    J Interv Card Electrophysiol; 2023 Aug; 66(5):1265-1267. PubMed ID: 36525170
    [No Abstract]   [Full Text] [Related]  

  • 14. Amiodarone in congestive heart failure.
    Silver MJ; Young J; Topol EJ
    N Engl J Med; 1995 Dec; 333(24):1639-40; author reply 1640-1. PubMed ID: 7477207
    [No Abstract]   [Full Text] [Related]  

  • 15. Consequences of ventricular tachyarrhythmia in patients with a left ventricular assist device: Live recording in the ICU.
    Napp LC; Reinke T; Ius F; Schmitto JD; Haverich A; Bauersachs J
    Acute Card Care; 2015; 17(2):36-7. PubMed ID: 26458031
    [No Abstract]   [Full Text] [Related]  

  • 16. Amiodarone in congestive heart failure.
    Singh S
    Int J Clin Pract; 1998 Sep; 52(6):432-5. PubMed ID: 9894384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia.
    Haas NA; Camphausen CK
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1215-22. PubMed ID: 19026806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wide complex tachycardia causing congestive heart failure.
    Li VH; Mallick A; Concannon C; Li VY
    Pacing Clin Electrophysiol; 2011 Sep; 34(9):1154-7. PubMed ID: 21605135
    [No Abstract]   [Full Text] [Related]  

  • 19. Overview and meta-analysis of randomised trials of amiodarone in chronic heart failure.
    Piepoli M; Villani GQ; Ponikowski P; Wright A; Flather MD; Coats AJ
    Int J Cardiol; 1998 Sep; 66(1):1-10. PubMed ID: 9781781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent ventricular tachycardia in a patient with continuous flow left ventricle assist device: Successful management with radiofrequency ablation and medical treatment.
    Romano G; Raffa GM; Ruggieri A; Sgarito G; Falletta C; Sciacca S; Pilato M; Clemenza F
    Int J Cardiol; 2015; 190():198-200. PubMed ID: 25920023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.